Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications

被引：0
|
作者：
Onakpoya, I. [1 ]
Heneghan, C. [1 ]
Aronson, J. [1 ]
机构：
[1] Univ Oxford, Primary Care Hlth Sci, Oxford, England
来源：
DRUG SAFETY | 2015年 / 38卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P 127
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 50 条
  • [31] Post-marketing safety of antiseizure medications: Focus on serious adverse effects including drug reaction with eosinophilia and systemic symptoms (DRESS)
    Qian, Jingjing
    Xue, Xiangzhong
    Ezeja, Lotanna
    Boxx, Zachary
    Jackson, Cherry W.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2025, 125 : 37 - 43
  • [32] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
  • [33] Reductil marketing agreement - AstraZeneca and BASF will jointly market the anti-obesity drug
    Fox, S
    GENETIC ENGINEERING NEWS, 1999, 19 (17): : 15 - +
  • [34] POST-MARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS IN GENERAL-PRACTICE .1. SEARCH FOR NEW METHODS
    INMAN, WHW
    BRITISH MEDICAL JOURNAL, 1981, 282 (6270): : 1131 - 1132
  • [35] Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies
    Honvo, Germain
    Lengele, Laetitia
    Alokail, Majed
    Al-Daghri, Nasser
    Reginster, Jean-Yves
    Bruyere, Olivier
    DRUGS, 2025, 85 (04) : 505 - 555
  • [36] Twelve-Month Analysis of a Telehealth Obesity Treatment Provider Using Anti-Obesity Medications
    Ard, Jamy
    Hong, Young-Rock
    Foster, Gary
    Medcalf, Adam
    Nadolsky, Spencer
    Cardel, Michelle
    OBESITY, 2024, 32 : 186 - 186
  • [37] Comparing Cardiovascular Safety Profile Of Anti-Obesity Medications - A FAERS Database Analysis
    Patel, Riya
    Pandya, Krutarth
    Shah, Kruti
    Bhakta, Shyam
    OBESITY, 2023, 31 : 225 - 225
  • [38] Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions
    Grosso, Anthony
    Douglas, Ian
    Hingorani, Aroon
    MacAllister, Raymond
    Smeeth, Liam
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 689 - 694
  • [39] POST-MARKETING ADVERSE EVENTS OF ONCOLOGY MEDICATIONS WITH BREAKTHROUGH THERAPY DESIGNATION CORRELATED WITH TIME ON MARKET AND MARKET SHARE
    Heitlage, V
    Farley, J. F.
    Shah, R.
    Tyagi, H.
    Stenehjem, D.
    VALUE IN HEALTH, 2022, 25 (07) : S460 - S460
  • [40] TNF ANTAGONIST DRUG SAFETY ASSESSMENT BY PHARMACOVIGILANCE SIGNALING AND POST-MARKETING ADVERSE EVENT REPORTS
    Cavaco, M.
    Araujo, F.
    Eurico Fonseca, J.
    Goncalves, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 784 - 785
12345